Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
100mg
DRUG
2 trials
Sponsors
Biohaven Pharmaceuticals Inc.
, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions
Diabetic Neuropathy Peripheral
Obsessive Compulsive Disorder
Phase 1
Study on Safety, Absorption and Metabolism of SYHA1402 Tablets in Healthy People
Completed
NCT03988413
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Diabetic Neuropathy Peripheral
Start: 2019-08-05
End: 2020-01-14
Updated: 2020-04-30
Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Completed
CTIS2024-514585-39-00
Biohaven Pharmaceuticals Inc.
Obsessive Compulsive Disorder
Start: 2021-07-12
End: 2025-01-11
Target: 100
Updated: 2025-01-29
Related Papers
Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects.
2023-04-24